Investigación

Tratamiento del cáncer pediátrico

Buscador de publicaciones

Publicaciones

  • Di Cataldo A, Agodi A, Balaguer J, Garaventa A, Barchitta M, Segura V, Bianchi M, Castel V, Castellano A, Cesaro S, Couselo JM, Cruz-Martínez O, D'Angelo P, De Bernardi B, Donat J, de Andoin NG, Hernandez MI, La Spina M, Lillo M, Lopez-Almaraz R, Luksch R, Mastrangelo S, Mateos E, Molina J, Moscheo C, Mura R, Porta F, Russo G, Tondo A, Torrent M, Vetrella S, Villegas JA, Viscardi E, Zanazzo GA and Cañete A.

    Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

    CLINICAL & TRANSLATIONAL ONCOLOGY . 19(1): 76-83. Nº de citas: 9

    [doi:10.1007/s12094-016-1505-1]

  • Greenfield JP, Castañeda A, George E, Kieran MW and Morales-La Madrid A.

    Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France

    PEDIATRIC BLOOD & CANCER . 63(12): 2072-2077. Nº de citas: 15

    [doi:10.1002/pbc.26169]

  • Vilà-Ubach M, García A, Girotti A, Alonso M, Rodríguez-Cabello JC, González-Vázquez A, Planell JA, Engel E, Buján J, García-Honduvilla N and Vallet-Regí M.

    3D silicon doped hydroxyapatite scaffolds decorated with Elastin-like Recombinamers for bone regenerative medicine

    ACTA BIOMATERIALIA . 45: 349-356. Nº de citas: 20

    [doi:10.1016/j.actbio.2016.09.016]

  • Figueras-Nart I, Vicente-Villa MA, Sánchez-Schmidt J, Jou-Munoz C, Bordas-Orpinell X, Celis-Passini VP, Cruz-Martínez O and González-Enseñat MA.

    Langerhans cell histiocytosis presenting as fingernail changes.

    JAAD case reports . 2(6): 485-487.

    [doi:10.1016/j.jdcr.2016.05.005]

  • Moreno L, García Ariza MA, Cruz-Martínez O, Calvo C, Fuster JL, Salinas JA, Moscardo C, Portugal R, Merino JM and Madero L.

    Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents

    ANALES DE PEDIATRIA . 85(5): 2741-2748.

    [doi:10.1016/j.anpedi.2016.02.007]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de citas: 23

    [doi:10.1016/j.canlet.2016.06.012]

  • Jansen MH, Lagerweij T, Sewing AC, Vugts DJ, van Vuurden DG, Molthoff CF, Caretti V, Veringa SJ, Petersen N, Carcaboso AM, Noske DP, Vandertop WP, Wesseling P, van Dongen GA, Kaspers GJ and Hulleman E.

    Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models

    MOLECULAR CANCER THERAPEUTICS . 15(9): 2166-2174. Nº de citas: 49

    [doi:10.1158/1535-7163.MCT-15-0558]

  • Zacharoulis S, Morales-La Madrid A, Bandopadhayay P, Chi SN, Manley P, Ullrich NN, Marcus K, Goumnerova L, Scott RM, Proctor M, Young-Poussaint T, De Girolami U and Kieran MW.

    Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 38(6): 479-485. Nº de citas: 8

    [doi:10.1097/MPH.0000000000000627]

  • Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.

    Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells

    PLoS One . 11(7): . Nº de citas: 21

    [doi:10.1371/journal.pone.0160094]

  • Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.

    RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein

    Oncotarget . 7(29): 46283-46300. Nº de citas: 12

    [doi:10.18632/oncotarget.10092]